SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Rubin who wrote (353)12/7/1999 11:21:00 AM
From: MGV  Read Replies (1) of 413
 
Technicals are weak, no way around that but, fundamentals, if anything, are stronger with the interim decision in the ITC against VISX. The decision weakens the sustainability of the $250 procedure fee LVCI must pay VISX.

LVCI also was trading down, unjustifiably in my opinion, on the TLCV news yesterday of weaker procedure growth. TLCV is in different markets facing much higher competition. LVCI, just 2 weeks ago, indicated its November procedure volume was on a record setting pace.

Fundamentally, you have to consider buying here with the prospect of buying more if it goes lower.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext